肝硬化与甲状腺激素的相关性研究进展  

Research progress on the relationship between liver cirrhosis and thyroid hormones

作　　者：郑明云 何雅军[1] 刘序友[1] 张庆慧 王腾燕 杨杰伦 舒建昌[1] Zheng Mingyun;He Yajun;Liu Xuyou;Zhang Qinghui;Wang Tengyan;Yang Jielun;Shu Jianchang(Department of Gastroenterology,Guangzhou Red Cross Hospital Affiliated to Jinan University,Guangzhou 510220,China)

机构地区：[1]暨南大学附属广州红十字会医院消化内科,广州510220

出　　处：《中华肝脏病杂志》2022年第3期331-334,共4页Chinese Journal of Hepatology

摘　　要：肝脏与甲状腺激素之间存在复杂关系,肝脏在甲状腺激素的激活、失活、转运和代谢中起着重要作用。同时,甲状腺激素也会影响肝细胞的活动及肝脏的新陈代谢,如脂代谢、胆红素代谢等。肝硬化患者多存在甲状腺激素水平的异常改变,研究肝硬化患者甲状腺激素水平的变化,对判断肝硬化患者病情严重程度、预后及诊疗有一定的临床价值。现就肝硬化与甲状腺激素的相关性研究进展进行综述。There exists a complex relationship between liver and thyroid hormones.Liver plays an important role in the activation,inactivation,transportation,and metabolism of thyroid hormones.At the same time,thyroid hormones also affect hepatocytes activity and liver metabolism,such as lipid and bilirubin metabolism.Importantly,thyroid hormone levels often change abnormally in patients with liver cirrhosis.Therefore,studying the change of thyroid hormone levels in patients with liver cirrhosis has a certain clinical value for assessing the severity,prognosis,diagnosis and treatment.This paper reviews the research progress on the relationship between liver cirrhosis and thyroid hormone.

关 键 词：肝硬化 甲状腺激素 相关性 临床诊疗 

分 类 号：R575.2[医药卫生—消化系统]